0000929638-24-002577.txt : 20240724 0000929638-24-002577.hdr.sgml : 20240724 20240724182658 ACCESSION NUMBER: 0000929638-24-002577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240722 FILED AS OF DATE: 20240724 DATE AS OF CHANGE: 20240724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooper Ronald Harold Wilfred CENTRAL INDEX KEY: 0001676880 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41854 FILM NUMBER: 241139249 MAIL ADDRESS: STREET 1: C/O GENOCEA BIOSCIENCES, INC. STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: enGene Holdings Inc. CENTRAL INDEX KEY: 0001980845 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 BUSINESS PHONE: (514) 332-4888 MAIL ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 4 1 form4.xml X0508 4 2024-07-22 0001980845 enGene Holdings Inc. ENGN 0001676880 Cooper Ronald Harold Wilfred C/O 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 QUEBEC, CANADA true true Chief Executive Officer false Stock Option (Right to Buy) 8.81 2024-07-22 4 A 0 1250000 0 A 2034-07-22 Common Shares 1250000 1250000 D Non-qualified stock option granted awarded pursuant to the Employment Agreement dated July 22, 2024 between Mr. Cooper and enGene USA, Inc. as an inducement award outside of the enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on July 22, 2025, which is the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years, subject to Mr. Cooper's continued service. /s/ Lee Giguere, as attorney-in-fact for the Reporting Person 2024-07-24